Cargando…
Identification of Risk Loci for Radiotoxicity in Prostate Cancer by Comprehensive Genotyping of TGFB1 and TGFBR1
SIMPLE SUMMARY: Genetic variability in transforming growth factor beta pathway (TGFB) has been reported to affect adverse events in radiotherapy. We investigated 40 germline polymorphisms in peripheral blood cells, covering the entire common genetic variability in the TGFβ1 ligand (gene TGFB1) and t...
Autores principales: | Guhlich, Manuel, Hubert, Laura, Mergler, Caroline Patricia Nadine, Rave-Fraenk, Margret, Dröge, Leif Hendrik, Leu, Martin, Schmidberger, Heinz, Rieken, Stefan, Hille, Andrea, Schirmer, Markus Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582951/ https://www.ncbi.nlm.nih.gov/pubmed/34771749 http://dx.doi.org/10.3390/cancers13215585 |
Ejemplares similares
-
8-Oxoguanine DNA Glycosylase (OGG1) Cys326 Variant: Increased Risk for Worse Outcome of Patients with Locally Advanced Rectal Cancer after Multimodal Therapy
por: Leu, Martin, et al.
Publicado: (2021) -
Postoperative Radiochemotherapy Using Modern Radiotherapy Techniques in Elderly Patients with Head and Neck Squamous Cell Carcinoma: The Challenge of Weighing Up Benefits and Harms of Treatment Modalities in Clinical Practice
por: Leu, Martin, et al.
Publicado: (2021) -
Evaluation of Prognosticators and Treatment-Related Side Effects in Patients Irradiated Postoperatively for Endometrial Cancer
por: Leu, Martin, et al.
Publicado: (2020) -
Preoperative Radiochemotherapy in Esophageal Squamous Cell Cancer with 5-Fluorouracil/Cisplatin or Carboplatin/Paclitaxel: Treatment Practice over a 20-Year Period and Implications for the Individual Treatment Modalities
por: Dröge, Leif Hendrik, et al.
Publicado: (2021) -
TGFB1 and TGFBR1 polymorphisms and breast cancer risk in the Nurses' Health Study
por: Cox, David G, et al.
Publicado: (2007)